Pi Campus
VC Fund
Rome, Italy
Pi Campus is a VC fund in Rome focused on Software and Mobile. Pi Campus is both a startup district and a venture fund investing in talents. We provide money in Seed and Pre-seed rounds to support the development of startups. Moreover we also offer to those who need it mentoring and the best possible working environment for them to grow: free desks for 6 months in one of our villas.
- Total investments:
- 57
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Pi Campus invests in
Stages Pi Campus invests in
Countries Pi Campus invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $125k–$7M
- Angel
- $400k–$1M
- Pre-Seed
- $100k–$1.6M
Investment Focus
Industry
- Software 10 (18%)
- Mobile 6 (11%)
- Biotechnology 6 (11%)
- E-Commerce 5 (9%)
- Health Care 5 (9%)
Stage
- Seed 30 (53%)
- Pre-Seed 9 (16%)
- Angel 4 (7%)
- Venture - Series Unknown 4 (7%)
- Equity Crowdfunding 2 (4%)
Country
- Italy 19 (33%)
- United States 14 (25%)
- United Kingdom 6 (11%)
- Mexico 2 (4%)
- Spain 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Silvio Gulizia
Head of Communication and Events
|
Head of Communication and Events | Total investments: 0 | Find email | |
Valerio Lanni
Wild Card
|
Wild Card | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cyberwave provides an AI-native robotics platform enabling developers to build, test, and deploy autonomous systems for robots and assets. | $8.1M / Seed / Oct 08, 2025 | ||
| Intron provides clinical speech recognition for 200+ accents spoken in developing countries starting with Africa, reducing documentation time by 6x so doctors can spend more time with patients | $1.6M / Pre-Seed / Jul 25, 2024 | ||
| Loquis is a travel podcasting platform to listen to and discover the world through geo-localized podcasts. They provide an audio podcast platform for travelers on public transport. They also provide podcasts for people while walking and driving. | $4.1M / Venture - Series Unknown / May 06, 2024 | ||
| Fondo helps with bookkeeping and beyond so founders can grow their businesses with more resources. The company strives to help founders build an enduring business by taking work off of their plate, providing them with the data needed to make key business decisions, and making sure the startup is in compliance at the state and federal level. | $1.2M / Pre-Seed / Feb 13, 2023 | ||
| Sixfold Bioscience engineers programmable oligonucleotide delivery systems are able to deliver RNA exclusively to diseased cells. It is based in London. | $2.2M / Seed / Dec 02, 2021 | ||
| Turion Space provides a spacecraft to remove orbital debris and services to existing satellites. The spacecraft will rendezvous and dock with current satellites and large debris objects using vision sensors and robotic arms. Utilizing the onboard propulsion system, the spacecraft will either deorbit or change the orbit of the debris object orsatellite. | $6.2M / Seed / Sep 01, 2021 | ||
| Allelica is a genomics software company driving the transition of Polygenic Risk Score from Genomic research to clinical application. The company uses cutting-edge genomics technology and machine learning algorithms to accelerate research and translational clinical genomics in Precisione Medicine. It was founded in 2018 and is headquartered inNew York, United States. | $1.8M / Seed / Mar 05, 2021 | ||
| Tope University aims to democratize higher education. We develop masters programs that are taught by the best entrepreneurs and business leaders instead of academics. Our methodology is based on microlearning and focuses on highly practical and key educational concepts. Our students learn as if they were watching Netflix. They only need 20 minutesa day over a period of 10 months. Also, they can boost their networking trough events and workshops within their region. | Seed / Nov 12, 2020 | ||
| Born in 2016, InSilicoTrials is a startup founded by a team of life science, cybersecurity and digital innovation experts, which aims to revolutionize healthcare through modeling & simulation. Today, the very long and expensive development and certification processes of new drugs and medical devices are becoming unsustainable. Simulation canreduce these costs up to 50% and greatly accelerate the go-to-market of new products. Regulatory agencies are pushing companies to adopt these practices, but many of these lack the IT infrastructure, expensive software, and high expertise needed to develop and use models. InSilicoTrials solves these problems by collecting the best models available in universities worldwide and then embedding them in a scalable IT platform, which makes it easier to find the right model, use it without specific knowledge and pay for the resources you use. This is possible because the InSilicoTrials team covers a broad range of expertise in IT and cloud solutions, scientific data management, pharmaceutical and biomedical R&D. All InSilicoTrials models are validated to support the product’s approval by the regulatory. Scientists, researchers and clinicians can develop and run their own models or access the best models selected by the InSilicoTrials R&D team. Simulation is a key factor to cut in vitro and in vivo testing costs, accelerate the go-to-market of new drugs, and also to create custom-made medical devices instead of the standard-size devices that are implanted today and frequently cause problems. InSilicoTrials is the first cloud-based platform that provides healthcare companies and researchers with easy-to-use tools to perform complex computational modeling and simulation for drug and medical device development. This cutting-edge technology can increase the quality of life of millions of patients by allowing cheaper treatments, bringing innovative drugs to the market in a shorter time, together with personalized cures and new solutions for rare diseases. | $3.5M / Seed / Jul 30, 2020 | ||
| Hyris offers its partners and clients a disruptive platform that enables genetic testing of biological samples in any setting, at any time, with real time access to results on its dedicated cloud based software platform. | $2.8M / Series A / May 27, 2020 | ||
| See all 57 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Pi Campus invest in?
Pi Campus invests primarily in Software, Mobile and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 57 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Pi Campus's check size?
Pi Campus typically joins rounds of $125k–$7M at Seed, $400k–$1M at Angel and $100k–$1.6M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Pi Campus participates in.
How do I contact Pi Campus?
Public channels for Pi Campus include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pi Campus?
The team at Pi Campus includes Silvio Gulizia (Head of Communication and Events) and Valerio Lanni (Wild Card). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
